RAPT Therapeutics
Manufacturing · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
561 Eccles Ave, South San Francisco, Cal...Phone Number
(650) 489-9000Website
www.rapt.comRevenue
$19.8 MillionStock Symbol
RAPTIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About RAPT Therapeutics
RAPT Therapeutics is a clinical stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases.Explore more
RAPT Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is RAPT Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if RAPT Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on RAPT Therapeutics recently announced quarterly report
Check out if RAPT Therapeutics is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when RAPT Therapeutics launches new products
Congratulate Masked Content for being promoted to Masked Content at RAPT Therapeutics
RAPT Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if RAPT Therapeutics had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once RAPT Therapeutics has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to RAPT Therapeutics
Compare insights from companies similar to RAPT Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
RAPT Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
RAPT Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about RAPT Therapeutics.
RAPT Therapeutics financials insights
Gather financial insights about RAPT Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Share Placement
$50M
2024
Share Placement
$150M
RAPT Therapeutics Tech Stack
A closer look at the technologies used by RAPT Therapeutics
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
Project
Laboratory Operations, Medical Research, Clinical Operations
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Project
RAPT Therapeutics has announced that the primary endpoint for its Phase II study of RPT904 was change from baseline in UAS7 at weeks 8, 12, and 16. Secondary endpoints included complete response (UAS7=0), itch severity, hives severity, angioedema severity, and quality of life.
Research & Development, Pharmaceuticals, Clinical Operations
Project
Research & Development, Pharmaceuticals, Clinical Operations
RAPT Therapeutics News & Media
This Investor Built a $56 Million Position in RAPT Last Quarter. It Was Just Acquired for $58 Per Share
RAPT Therapeutics develops oral therapies for cancer and inflammation, with key drug candidates currently in clinical trials.GSK completes acquisition of RAPT Therapeutics
GSK plc (LSE/NYSE: GSK) today announced the completion of its previously announced acquisition of RAPT TherapeuticsBRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RAPT Therapeutics, Inc. (Nasdaq – RAPT), Penumbra, Inc. (NYSE – PEN), Calavo Growers, Inc. (Nasdaq – CVGW), FONAR Corporation (Nasdaq - FONR)
BALA CYNWYD, Pa., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding RAPT Therapeutics
Sign Up For FreeTo access detailed company insights
RAPT Therapeutics is a clinical stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases.... Read More
